| Regulatory reference: | Guidelines to Commission Regulation (EU) No 655/2013 |
| Claim: | Non-comedogenic and Sebum-regulator |
| Application field: | Visage and body cosmetics for oily skin. |
| Description of the test: | Sebometric measurements in triplicate performed with Sebometer® at T=0 and T=X days after the treatment. Measurements will be performed on the cheeks after treatment. The untreated forehead will be used as a control. The measurements will compensate for circadian rhythms and will therefore be performed at the same time during the day. Open and closed comedones will be counted under Wood’s lamp illumination. Clinical evaluation of high resolution imaging will be performed using a contrast system at T=0 and after X days of treatment. |
| Regulatory reference: | Proprietary method |
| Claim: | Sebum-regulator |
| Application field: | Active ingredients or finished products. |
| Description of the test: | Quantification of the changes in the gene expression of 5α-reductase in human dermal papilla cells. Demonstration of the efficacy of the ingredient or finished product in reducing the expression of mRNA codifying for 5α-reductase type I or II. |
| Regulatory reference: | Proprietary method |
| Claim: | Sebum-regulator and Anti-hair loss |
| Application field: | Active ingredients or finished products. |
| Description of the test: | Quantification of the changes in the gene expression of 5α-reductase in murine Balb/3T3 fibroblasts. Demonstration of the efficacy of the ingredient or finished product in reducing the expression of mRNA codifying for 5α-reductase type I or II. |
| Regulatory reference: | Proprietary method |
| Claim: | Sebum-regulator and Anti-hair loss |
| Application field: | Active ingredients or finished products. |
| Description of the test: | Analysis of the in vitro expression of the 5α-reductase enzyme by real time PCR in comparison with untreated substrates for the evaluation of inhibition effects. Demonstration of the efficacy of the ingredient or finished product in reducing the expression of mRNA codifying for 5α-reductase type I or II. |
| Regulatory reference: | Proprietary method |
| Claim: | Anti-cellulite and Sebum-regulator |
| Application field: | Active ingredients or finished products. |
| Description of the test: | Analysis of the activation of the activity of enzymatic lipase in a controlled triglyceride hydrolysis reaction. |